Experiences of cystic fibrosis newborn screening and genetic counseling

被引:0
|
作者
Kimberly Foil
Lillian Christon
Cheryl Kerrigan
Patrick A. Flume
Jaclyn Drinkwater
Sylvia Szentpetery
机构
[1] Medical University of South Carolina,Department of Medicine
[2] Medical University of South Carolina,Department Psychiatry and Behavioral Sciences
[3] Medical University of South Carolina,Department of Pediatrics
来源
Journal of Community Genetics | 2023年 / 14卷
关键词
Cystic fibrosis; Newborn screening; Genetic counseling; Parents; Distress; Comprehension;
D O I
暂无
中图分类号
学科分类号
摘要
The South Carolina cystic fibrosis (CF) newborn screening (NBS) program changed in 2019 to include CFTR genotyping for babies with top 4% immunoreactive trypsinogen, which improves sensitivity and timeliness but increases carrier detection. Carrier identification has genetic implications for the family and parents of NBS+ babies have increased emotional distress. Genetic counseling (GC) may increase parent understanding and reduce anxiety yet is not uniformly offered at CF centers. We report our early results after implementing GC for NBS+ families at the time of sweat chloride testing based on GC availability, which resulted in an unselected GC− control arm. Sixteen mothers (GC+ = 9, GC− = 7) participated in an online survey about their experience. Responses were analyzed in aggregate and for differences between GC+ and GC− groups. All-respondent sadness and anxiety increased with notification of the NBS+ result and decreased after sweat test results. Anxiety and sadness were greater in GC− compared to GC+ until after the diagnosis was resolved, though emotional differences between the groups were not statistically significant. On a scale of 0 = not at all to 10 = extremely, GC was rated very helpful (mean 9.0, range 5–10), informative (mean 8.9, range 4–10), comforting (mean 9.1, range 6–10), and minimally distracting (mean 1.8, range 0–9). All participants correctly identified that a risk for a child to have CF exists when both parents are (at least) carriers. Delivery of NBS results to respondents varied by timing, informant, and information given. The child’s pediatrician notified 10 (62.5%) of the NBS+ result. Parents felt they were notified in a timely manner (68.8%), by someone knowledgeable about NBS (62.5%), the sweat test (62.5%), CF (43.8%), and genetics (43.8%) and who cared about them (81.3%). Parents felt worried (81.3%), confused (81.3%), empowered (25%), and other (sad, shocked, scared, overwhelmed, devastated, defeated). Data from this single-center study suggest benefit of GC, that families would value earlier contact with an expert, and that prompt diagnostic resolution may reduce duration of parental distress.
引用
收藏
页码:621 / 626
页数:5
相关论文
共 50 条
  • [31] Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis
    Massie, John
    Forbes, Robin
    duSart, Desiree
    Bankier, Agnes
    Delatycki, Martin B.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (11) : 721 - 723
  • [32] Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
    Marcao, Ana
    Barreto, Celeste
    Pereira, Luisa
    Vaz, Luisa Guedes
    Cavaco, Jose
    Casimiro, Ana
    Felix, Miguel
    Silva, Teresa Reis
    Barbosa, Telma
    Freitas, Cristina
    Nunes, Sidonia
    Felicio, Veronica
    Lopes, Lurdes
    Amaral, Margarida
    Vilarinho, Laura
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2018, 4 (03)
  • [33] Cystic fibrosis carrier screening effects on birth prevalence and newborn screening
    Castellani, Carlo
    Picci, Luigi
    Tridello, Gloria
    Casati, Elia
    Tamanini, Anna
    Bartoloni, Lucia
    Scarpa, Maurizio
    Assael, Baroukh M.
    GENETICS IN MEDICINE, 2016, 18 (02) : 145 - 151
  • [34] Cystic fibrosis newborn screening does not delay the identification of cystic fibrosis in children with negative results
    MacLean, Joanna E.
    Solomon, Melinda
    Corey, Mary
    Selvadurai, Hiran
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (05) : 333 - 337
  • [35] Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report
    Comeau, Anne Marie
    Accurso, Frank J.
    White, Terry B.
    Campbell, Preston W., III
    Hoffman, Gary
    Parad, Richard B.
    Wilfond, Benjamin S.
    Rosenfeld, Margaret
    Sontag, Marci K.
    Massie, John
    Farrell, Philip M.
    O'Sullivan, Brian P.
    PEDIATRICS, 2007, 119 (02) : E495 - E518
  • [36] Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy
    Collins, Jenelle L.
    La Pean, Alison
    O'Tool, Faith
    Eskra, Kerry L.
    Roedl, Sara J.
    Tluczek, Audrey
    Farrell, Michael H.
    PATIENT EDUCATION AND COUNSELING, 2013, 90 (03) : 378 - 385
  • [37] Genomic Counseling in the Newborn Period: Experiences and Views of Genetic Counselors
    Nardini, Monica D.
    Matthews, Anne L.
    McCandless, Shawn E.
    Baumanis, Larisa
    Goldenberg, Aaron J.
    JOURNAL OF GENETIC COUNSELING, 2014, 23 (04) : 506 - 515
  • [38] Parents' experience with positive newborn screening results for cystic fibrosis
    Brockow, Inken
    Nennstiel, Uta
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (06) : 803 - 809
  • [39] Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
    Sherman, Victoria
    Kondratyeva, Elena
    Kashirskaya, Nataliya
    Voronkova, Anna
    Nikonova, Victoria
    Zhekaite, Elena
    Kutsev, Sergey
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (02)
  • [40] Newborn screening for cystic fibrosis: Is there benefit for everyone?
    Course, C. W.
    Hanks, R.
    PAEDIATRIC RESPIRATORY REVIEWS, 2019, 31 : 3 - 5